Biotech News
-
XPhyto Partner Receives ISO Certification for 25-Minute COVID-19 RT-PCR Test
March 10, 2021 (Source) — XPhyto Therapeutics Corp. (CSE:XPHY / OTCQB:XPHYF / FSE:4XT) (“XPhyto” or the “Company”), and its…
-
DIAGNOS, following a successful Proof-of-Concept (POC) pilot study, is finalising its new application CARA-STROKE to address Stroke prevention and management, a market estimated at $36 Billion
March 9, 2021 (Source) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader…
-
Sixth Wave’s Polymer Imprint Detects SARS-CoV-2 During Initial Testing
March 9, 2021 (Source) — Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: ATURF) (FSE: AHUH) (“Sixth Wave”, “SIXW”…
-
DIAGNOS and the third largest optical retailer in Costa Rica Piloting CARA and its Telemedicine technology
March 4, 2021 (Source) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in…
-
XPhyto Completes Corporate Rebranding and Launches New Website
March 4, 2021 (Source) — XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) (“XPhyto” or the “Company”), is pleased to announce that the…
-
Perimeter Medical Imaging AI Announces U.S. FDA 510(k) Clearance for OCT Imaging System
March 1, 2021 (Source) — Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical technology…
-
XPhyto Provides Updated Comments on Promotional and Marketing Activity
February 26, 2021 (Source) — XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) (“XPhyto” or the “Company”) at the request of IIROC and the…
-
Perimeter Medical Imaging AI Provides Update on Exercise of Warrants
February 26, 2021 (Source) — Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical technology…
-
Valeo Pharma Reports its 2020 Fourth Quarter and Year-End Results and Highlights
February 24, 2021 (Source) — Q4-20 net revenues of $2.2 million, up 76 % vs Q4-19, 2020 net revenues…
-
XPhyto Places First Order for 25-Minute Covid-19 RT-PCR Tests
February 24, 2021 (Source) — XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) (“XPhyto” or the “Company”), is pleased to announce that it…
